interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Vadadustat

Generic competition · all medicines · read 12 November 2026

Is there a generic of Vadadustat, and who makes it?

Vadadustat appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Vadadustat1 dosage-form group in the Orange Book
0generic makers listed
  1. Vadadustat appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Vafseo. No generic is listed as marketed.

2020202520302035204001brand 2024data datePatent 8940773 listed to expire 26 June 2027Patent RE47437 listed to expire 26 June 2027Patent 8598210 listed to expire 26 June 2027Patent 8343952 listed to expire 14 August 2027Patent 7811595 listed to expire 13 March 2028Patent 8323671 listed to expire 3 April 2028Patent 12569474 listed to expire 4 June 2034Patent 11857543 listed to expire 9 June 2034Patent 11065237 listed to expire 14 November 2034Patent 9987262 listed to expire 14 November 2034Patent 9701636 listed to expire 14 November 2034Patent 10149842 listed to expire 14 November 2034Patent 11844756 listed to expire 31 March 2036Patent 11324734 listed to expire 31 March 2036Exclusivity NCE to 27 March 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 27 March 2029Exclusivity NCE Vafseo
  • 26 June 2027Patent 8940773
  • 26 June 2027Patent RE47437 drug substance
  • 26 June 2027Patent 8598210 drug substance
  • 14 August 2027Patent 8343952 drug substance
  • 13 March 2028Patent 7811595 drug substance
  • 3 April 2028Patent 8323671
  • 4 June 2034Patent 12569474
  • 9 June 2034Patent 11857543

6 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.